# European Organisation for Research and Treatment of Cancer (EORTC), the European Association for Cancer Research (EACR), the European CanCer Organisation (ECCO) and the European Society of Mastology (EUSOMA).

> organisation involved in scholarly research

**Wikidata**: [Q74556692](https://www.wikidata.org/wiki/Q74556692)  
**Source**: https://4ort.xyz/entity/european-organisation-for-research-and-treatment-of-cancer-eortc-the-european-association-for-cancer-research-eacr-the-e

## Summary
The European Organisation for Research and Treatment of Cancer (EORTC), European Association for Cancer Research (EACR), European CanCer Organisation (ECCO), and European Society of Mastology (EUSOMA) are leading European research institutes dedicated to advancing cancer research, treatment, and education. They foster collaboration across disciplines to improve patient outcomes and accelerate scientific discovery. EORTC is specifically noted for publishing the *EJC Supplements* journal.

## Key Facts
- EORTC, EACR, ECCO, and EUSOMA are classified as research institutes focused on cancer.
- EORTC is based in the United Kingdom (reference: Wikidata item Q69652283).
- EORTC publishes the *EJC Supplements* journal, affiliated with Elsevier (reference: ISSN 1359-6349).
- The organizations emphasize scholarly research, clinical trials, and multidisciplinary approaches to cancer care.
- EUSOMA specializes in mastology, addressing breast cancer and related diseases.

## FAQs
### Q: What is the primary focus of these organizations?
A: They prioritize cancer research, treatment innovation, and education through collaborative efforts across Europe.

### Q: Where is EORTC based?
A: EORTC is based in the United Kingdom, as documented in its Wikidata entry.

### Q: What distinguishes EUSOMA from the other organizations?
A: EUSOMA focuses specifically on mastology, including breast cancer research and clinical practice.

## Why It Matters
These organizations play a critical role in shaping Europe’s cancer research landscape. By promoting interdisciplinary collaboration, they drive advancements in early detection, treatment protocols, and patient care. EORTC’s publication of *EJC Supplements* highlights its commitment to disseminating high-impact research. Together, they address the complexity of cancer through integrated strategies, bridging gaps between laboratory science and clinical practice. Their work directly impacts survival rates, quality of life for patients, and the global understanding of cancer biology.

## Notable For
- EORTC’s publication of the *EJC Supplements* journal, a key platform for cancer research.
- EUSOMA’s specialized focus on breast cancer and mastology.
- ECCO’s comprehensive approach to cancer care, integrating research, education, and policy.
- Facilitating large-scale clinical trials and data sharing across European institutions.

## Body
### Organizational Overview
- **EORTC**: A UK-based research institute renowned for its clinical trials and publication of *EJC Supplements*, which features peer-reviewed studies on cancer treatment and outcomes.
- **EACR**: Dedicated to promoting basic and translational cancer research through conferences, training, and networking opportunities for scientists.
- **ECCO**: Emphasizes a multidisciplinary framework for cancer care, combining research, education, and advocacy to improve European healthcare systems.
- **EUSOMA**: Concentrates on advancing breast cancer research, surgical techniques, and patient management through specialized training and guidelines.

### Research and Collaboration
- The organizations collectively support studies on cancer biology, therapeutic strategies, and survivorship.
- They facilitate partnerships among researchers, clinicians, and policymakers to align European cancer care with evolving scientific evidence.
- EORTC’s clinical trial networks and EACR’s academic forums exemplify their commitment to translating research into practice.

## References

1. [Directory of Open Access Journals](http://www.elsevier.com/journals/ejc-supplements/1359-6349/open-access-journal)